The Fic family of adenylyltransferases, defined by a core HPFx(D/E)GN(G/K)R motif, consists of over 2,700 proteins found in organisms from bacteria to humans. The immunoglobulin-binding protein A (IbpA) from the bacterial pathogen Histophilus somni contains two Fic domains that adenylylate the switch1 tyrosine residue of Rho-family GTPases, allowing the bacteria to subvert host defenses. Here we present the structure of the second Fic domain of IbpA (IbpAFic2) in complex with its substrate, Cdc42. IbpAFic2bound Cdc42 mimics the GDI-bound state of Rho GTPases, with both its switch1 and switch2 regions gripped by IbpAFic2. Mutations disrupting the IbpAFic2-Cdc42 interface impair adenylylation and cytotoxicity. Notably, the switch1 tyrosine of Cdc42 is adenylylated in the structure, providing the first structural view for this post-translational modification. We also show that the nucleotide-binding mechanism is conserved among Fic proteins and propose a catalytic mechanism for this recently discovered family of enzymes.
a r t i c l e s
The Fic (filamentation induced by cyclic AMP) domains are defined by a core HPFx(D/E)GN(G/K)R motif and are conserved from bacteria to humans 1 . Over 2,700 Fic proteins exist in nature, and until recently, their biological activity had remained elusive. Our laboratory and others recently reported that Fic domain proteins from two pathogenic bacteria use ATP to catalyze the addition of adenosine monophosphate (AMP) to target host proteins 2, 3 . Specifically, IbpA from Histophilus somni causes collapse of the host-cell actin cytoskeleton by catalyzing the addition of AMP to the three mammalian Rhofamily GTPases RhoA, Rac1 and Cdc42 (refs. 2,4) . The modification occurs on a conserved tyrosine residue in the switch1 region of these GTPases, resulting in their inability to interact with the downstream effectors. In contrast, VopS from Vibrio parahaemolyticus catalyzes the addition of AMP to a conserved switch1 threonine residue in the same family of GTPases 3 .
It is highly likely that all Fic proteins use the conserved HPFx(D/E) GN(G/K)R motif to catalyze the addition of AMP, or 'adenylylation' , of target proteins. A small branch of the Fic proteins known as death on curing (Doc) has been previously studied in the bacteriophage P1 of Escherichia coli as part of a toxin-antitoxin module 5 . Doc triggers cytotoxicity by associating with the 30S ribosomal subunits and inhibiting translation elongation 6 . The exact nature of Doc function remains unclear; however, Doc also harbors a central HPFx(D/E)GN(G/K)R motif. Mutating the conserved histidine or aspartate in this motif attenuates the cytotoxicity of Doc, suggesting an enzymatic scheme 7 .
Fic domain-containing proteins are found in many species of bacterial pathogens. In particular, a list of effector proteins from pathogenic bacteria feature this domain, such as AnkX from Legionella pneumophila 8 , BepA from Bartonella spp. 9 , AvrAC from Xanthomonas campestris 10 and PfhB2 from Pasteurella multocida 11 . It remains to be determined whether these effectors also target the Rho-family GTPases. Structural analyses further expand the Fic/Doc family to include AvrB, an effector protein of the plant pathogen Pseudomonas syringae [12] [13] [14] , even though AvrB lacks the HPFx(D/E)GN(G/K)R motif. It is currently unknown whether AvrB represents a functional member of this family. The large number of Fic domain-containing proteins also makes it unlikely that they all function in a pathogenic setting. The presence of a Fic protein called Huntingtin yeast-interacting protein E (HYPE) in higher eukaryotes, including humans, suggests that Fic-mediated adenylylation might represent a new signaling paradigm that regulates cellular processes 2 . As such, a deeper understanding of these Fic adenylyltransferases at a structural and functional level will likely shed light on both their physiology and pathology.
The covalent addition of AMP to other proteins has been previously reported. In the late 1960s, adenylylation on tyrosine residues was reported for bacterial glutamine synthetase 15, 16 . Transient adenylylation of a C-terminal glycine residue or a catalytic lysine residue also occurs during the activation of ubiquitin and ubiquitin-like proteins 17, 18 as well as during DNA and RNA ligation processes 19, 20 . However, the Fic proteins share no homology with bacterial glutamine synthetase adenylyltransferases, the E1-like enzymes or the polynucleotide ligases. Although structures of several Fic domain proteins have been determined by structural genomics efforts 14, 21 (PDB 2F6S, 2G03, 3CUC, 3EQX and 2VZA), they were achieved before the enzymatic activity of this family of proteins was revealed and did not provide important insights into the catalytic mechanism of these proteins.
IbpA is a large protein that is composed of 4,095 residues. It contains an N-terminal secretion signal followed by a filamentous hemagglutinin (FHA) domain, which presumably contributes to its attachment to the host cell 22 . In its C-terminal region, it contains two consecutive Fic domains (Fic1 and Fic2), which share more than 70% sequence identity ( Supplementary Fig. 1 ) and appear functionally redundant in disrupting the host cell cytoskeleton 2 . A YopT cysteine protease homology domain resides at the C-terminal end of IbpA; however, this region is dispensable for cytotoxicity 2 . To further the understanding of the virulence action of H. somni and gain fundamental insights into the functional mechanism of the Fic proteins, we have performed structural and functional studies on the Fic domain of IbpA. Here we report the crystal structure of IbpAFic2 in complex with Cdc42. Notably, our structure captures an end product of the enzymatic reaction, in which the switch1 tyrosine of Cdc42 is adenylylated. Further, we have elucidated the nucleotide-binding mechanism of IbpAFic2, which is conserved and can be extrapolated to other Fic proteins. Together, these results significantly expand our understanding of this unique family of enzymes and provide compelling new insights into the functional mechanism of these proteins.
RESULTS

Structure of IbpAFic2
IbpAFic2, composed of residues 3482-3797 of IbpA, is highly stable and has a similar catalytic activity to larger fragments of Fic1 or Fic2. It crystallized under a condition containing zinc sulfate. The presence of zinc in the crystal is detected by fluorescence scanning at the synchrotron, even after the crystal is prewashed with zinc-free solution. As such, we have been able to determine the structure of IbpAFic2 using the single-wavelength anomalous dispersion (Zn-SAD) method ( Table 1) . The structure is refined to a final 1.85-Å resolution and reveals two zinc atoms bound per IbpAFic2 molecule, which are critical for mediating the crystal contact.
The overall structure of IbpAFic2 reveals an all-helical molecule containing 14 α-helices. It consists of two segments, an N-terminal helical module and a core Fic domain (Fig. 1) . The core Fic domain has a similar architecture to those of the Fic domains in other Fic protein structures ( Supplementary Fig. 2) , including Doc and AvrB, featuring a central helix-turn-helix motif (α11-α12) surrounded by six additional α-helices (α6, α8, α9, α10, α13 and α14). The highly conserved HPFx(D/E)GN(G/K)R sequence motif constitutes the α11-α12 loop as well as the first helical turn of α12. The N-terminal helical module is unique to IbpAFic2. In particular, helices α2, α3 and α4 form an independent 'arm' subdomain, which specifically recognizes the Rho-family GTPases (see below). It is noteworthy that several other Fic proteins have also evolved unique structural motifs besides the Fic domains ( Supplementary Fig. 2 ). Based on our knowledge of the structure and function of IbpAFic2, we speculate that the unique structural element in each Fic protein is responsible for substrate recognition, whereas the Fic domains execute a common catalytic function.
Structure of the IbpAFic2 H3717A-Cdc42 complex
To gain insights into the substrate-binding mechanism of IbpAFic2, we have determined the crystal structure of a catalytically compromised mutant, IbpAFic2 H3717A, in complex with Cdc42 at 2.3-Å resolution ( Table 1 and Fig. 2a ). Although IbpAFic2 is a monomer in solution (based on gel-filtration analysis) as well as in the crystal form described above, it emerges as a dimer in the IbpAFic2 H3717A-Cdc42 complex structure, leading to the formation of a 2:2 (IbpAFic2:Cdc42) tetramer in the asymmetric unit ( Fig. 2a ). There are no interactions between the two Cdc42 molecules in the tetramer. Comparison between the structures of apo and Cdc42bound IbpAFic2 showed that their overall similarity is high. The r.m.s. deviation between the two structures based on the Cα chains is 0.8 Å. Most of the structural differences are located in the arm domain and the long α9-α10 loop (Supplementary Fig. 3a ). In the dimer structure, the N-terminal half of the α9-α10 loop interacts with the backside of the arm domain to form the dimer interface, resulting in slight overall displacements of both regions ( Supplementary Fig. 3b ). The C-terminal half of the α9-α10 loop a r t i c l e s a r t i c l e s (residues 3668-3672), disordered in the monomeric structure, also adopts a concrete conformation and has a pivotal role in recognizing the switch1 region of Cdc42 (see below). The dimer interface buries ~923 Å 2 , or ~6% of the solvent-accessible surface, from each protein and is mediated mostly by polar interactions, many through water molecules. The residues involved in dimer formation are largely conserved between Fic1 and Fic2 ( Supplementary Table 1 ). Because there are two Fic domains in IbpA, we cannot rule out the possibility that the Fic domains form homo-or heterodimers within the cell. The functional significance of this remains to be explored.
IbpAFic2-bound Cdc42 mimics the GDI-bound state
Comparison of IbpAFic2-bound Cdc42 with available Rho-family protein structures reveals similarity to the Rho proteins in their GDP dissociation inhibitor (GDI)-bound states. When we used the Cdc42 structure in the IbpAFic2 H3717A-Cdc42 complex to search for similar structures in the protein database, Rac2 and Cdc42 in their GDIbound conformation were the best two matches 23 a r t i c l e s different functional states also reveal that the switch1 and switch2 regions adopt conformations most similar to the GDI-bound state (Fig. 2b) .
IbpAFic2 H3717A-Cdc42 interface
IbpAFic2 uses a tripartite mechanism of substrate recognition and mainly engages the switch1 and switch2 regions of Cdc42 (Fig. 3a) . The binding interface between IbpAFic2 and Cdc42 buries an average of ~1,142 Å 2 of solvent-accessible surface (1,170 Å 2 and 1,113 Å 2 for the two complexes in the asymmetric unit, respectively) from each protein, with the switch1 and switch2 interfaces each constituting ~440 Å 2 and ~610 Å 2 , respectively. A third binding interface involves the β1-α1 loop of Cdc42 and the α13-α14 loop of IbpAFic2. This interface is small (~90 Å 2 ) compared to the other two interfaces, so we will focus our discussion on the interactions mediated by the switch1 and switch2 regions of Cdc42.
At the switch1 region, where the target tyrosine (Tyr32 C ; Cdc42 residues are denoted with superscript C) is located, the side chains of Tyr32 C and Pro34 C make hydrophobic interactions with the side chains of Leu3668 and Lys3670 from the α9-α10 loop of IbpAFic2 (Fig. 3b) . In particular, the side chains of Leu3668 and Lys3670 form a 'clamp' , which locks the position of the Tyr32 C side chain in the correct orientation for modification. Mutating Leu3668 and Lys3670 to alanines substantially reduced the activity of IbpAFic2 toward the Rho-family proteins (Fig. 3c) . In addition to the hydrophobic contacts, a salt bridge between Asp38 C and Lys3533 and three main chain-main chain hydrogen bonds between two residues in Cdc42 (Thr35 C and Val33 C ) and two residues in IbpAFic2 (Asn3667 and Thr3669) also contribute to the interaction between IbpAFic2 and Cdc42 at this region.
The binding interface at the switch2 region is more extensive than that at the switch1 region and is mediated by the arm domain of IbpAFic2 (Fig. 3d) . The side chains of Tyr64 C , Arg66 C , Leu67 C , Leu70 C and Pro73 C pack against a hydrophobic patch on the surface of the IbpAFic2 arm domain, formed by Ile3535, Pro3536, Thr3539, Met3543, Phe3549, Ile3552, Leu3553, Gly3556, Ala3557 and Val3560. Several polar interactions are also present at this area, including two salt bridges formed between Asp63 C and Arg3563 and between Arg66 C and Glu3555. To assess the functional importance of the arm domain, we generated two double mutants, I3535E P3536E and I3552E L3553E. Both mutants display impaired activity toward the Rho-family proteins (Fig. 3c) . Reciprocally, a triple mutant of Cdc42 at the switch2 region, Y64A L67E L70E (YLL), was completely inert as a substrate of IbpAFic2, as were equivalent mutants of Rac1 (Y64A L67E L70E) and RhoA (Y66A L69E L72E) (Fig. 3e) . These data indicate that the arm domain dictates the ability of IbpAFic2 to recognize the Rho-family proteins via their switch2 regions and are consistent with our observation that a switch1 region peptide is not a good substrate of IbpAFic2 (data not shown). Notably, the same YLL residues are also required for VopSmediated adenylylation (Fig. 3e) . Although VopS adenylylates Rac1, RhoA and Cdc42 at a threonine residue, our data suggest that VopS might recognize the Rho-family proteins in a manner analogous to IbpAFic2. In agreement with our hypothesis, the recent reported structure of VopS shows that it contains a segment that resembles the arm domain of IbpAFic2 (ref. 25 ). 
A snapshot of Fic-mediated adenylylation
Although we used IbpAFic2 H3717A, a catalytically compromised mutant, in the cocrystallization experiments, the Tyr32 residues of both Cdc42 molecules in the crystal asymmetric unit are adenylylated ( Fig. 4a and Supplementary Fig. 4a ). We reason that this is caused by the residual enzyme activity of the mutant protein ( Supplementary Fig. 4b ) in conjunction with a long growth time for the crystals (several weeks). The AMP moiety attached to the Cdc42 molecule provides us with the first snapshot of this posttranslational modification at the molecular level. Because our complex structure essentially captures an end product of the enzymatic reaction, it also sheds light on the catalytic mechanism of IbpAFic2 and the Fic domain-containing proteins in general. The AMP moiety is bound within a surface pocket of IbpAFic2. The adenosine group of AMP is partially enclosed in a hydrophobic environment created by IbpAFic2 residues Ala3673, Phe3675, Ile3714, Gly3724, Pro3752, Ile3754 and Ile3755 (Figs. 3a and 4b) . This hydrophobic environment is critical for the function of IbpAFic2. Singleresidue substitution mutants such as A3673E, F3675A, G3724E and I3755E all had reduced or negligible enzymatic activity (Fig. 3c) . Besides the hydrophobic contacts, IbpAFic2 also forms a total of 11 hydrogen bond interactions with AMP, mediated by residues including Lys3670, Glu3671, Asn3672, Gly3722, Asn3723, Gly3724, Arg3728 and Gln3757 (Fig. 4b) . In particular, Gly3722, Asn3723 and Gly3724 in the HPFx(D/E)GN(G/K)R motif form four hydrogen bonds with the α-phosphate group of AMP, three of which are contributed by the main chain amide nitrogens of these residues. A sulfate ion binds at approximately the same location in our IbpAFic2 structure (Supplementary Fig. 5 ) and in two other Fic structures (H. pylori Fic and B. henselae BepA; PDB 2F6S and 2VZA), suggesting the presence of an 'anion hole' in this region. This is reminiscent of the glycine-rich phosphate-binding loops (P-loops) commonly seen in other nucleotide-binding proteins 26 . Two other residues important for hydrogen bonding with AMP are Arg3728 and Gln3757. Arg3728 forms two hydrogen bonds with the ribose group and thus serves as an important anchor at the middle of the adenine nucleotide. Gln3757 contributes two hydrogen bonds to interact with the adenine ring. Accordingly, R3728A Q3757A, a double mutant of IbpAFic2, also has reduced enzymatic activity compared with that of the wild-type protein (Fig. 3c) .
The three major elements involved in nucleotide binding, the hydrophobic adenosine-binding pocket, the ribose-coordinating arginine and the P-loop, are generally conserved in all the available Fic structures. When other Fic structures are superimposed on IbpAFic2, hydrophobic side chains are commonly seen in the vicinity of IbpAFic2 residues Ala3673, Phe3675, Ile3714, Pro3752, Ile3754 and Ile3755 (Fig. 4c,d and Supplementary Fig. 6) . Similarly, a conserved arginine always exists at the position corresponding to Arg3728 in IbpAFic2. α-Phosphate binding is largely mediated by the highly conserved HPFx(D/E)GN(G/K)R motif. These recurrent features again suggest that all the Fic domains perform a similar catalytic function. The substrates for most of the Fic proteins are currently unknown; however, we and others have noticed that these proteins can autoadenylylate in vitro in the presence of ATP 14 . It is currently unclear whether this autoadenylylation activity represents a nonspecific reaction or has functional consequences. Nevertheless, it provides us with a tool to probe the putative ATP binding site in these proteins. Mutation of residues corresponding to IbpAFic2 residues Phe3675, Gly3724 and Arg3728 in two of these proteins, N. meningitidis Fic (Fig. 4c) and H. pylori Fic (Fig. 4d) , substantially reduced their autoadenylylation (Fig. 4e) . These data further support the hypothesis that the ATP-binding mechanism is generally conserved in all the Fic proteins.
IbpAFic2 mutants show reduced cytotoxicity
In mammalian cells, the Fic domains of IbpA mediate adenylylation of the Rho-family proteins, causing the collapse of the actin cytoskeleton and drastic cell rounding 2, 27 . To further validate the biological importance of our findings from the above analyses, we expressed the various IbpAFic2 mutants as GFP fusion proteins in HeLa cells and evaluated their cytotoxicity. We monitored changes in cell morphology by fluorescence microscopy (Fig. 5a) . The nucleotide-binding mutant G3724E, which failed to adenylylate any of the Rho-family proteins in vitro, also completely lost its cell-rounding activity in vivo, highlighting the importance of this conserved glycine residue. This result was almost identical to that of the catalytically compromised histidine mutant H3717A. In addition, ~50% of the cells expressing I3552E L3553E (switch2-binding) or L3668A K3670A (switch1binding) and 20% of the cells expressing R3728A Q3757A (nucleotidebinding) remained morphologically normal, indicating a partial loss of function of IbpAFic2 due to these particular mutations (Fig. 5b) . The severity of cytotoxicity correlated with the protein-expression levels of these mutants as visualized by GFP intensity. Finally, three other mutants retaining reasonably high enzymatic activity (I3535E P3536E , F3675A and I3755E, Fig. 3c ) were still capable of inducing pronounced cell rounding (data not shown). Overall, our in vivo cytotoxicity results mirror the in vitro adenylylation activities of the IbpAFic2 mutants.
A possible catalytic mechanism
His3717 in IbpAFic2 is part of the highly conserved HPFx(D/E) GN(G/K)R motif. Mutation of this residue substantially lowers the 19, 20 and could then transfer the AMP group to the Rho proteins. The fact that the Fic proteins can autoadenylylate appears to be consistent with this hypothesis. However, several lines of evidence argue against this scenario. First, the H3717A mutant is not completely inactive (Supplementary Fig. 4b) . In fact, it catalyzed the adenylylation of Cdc42 in our complex crystal ( Fig. 2a) However, this appears not to be the case (Supplementary Fig. 7) . Furthermore, our attempts to capture an enzyme-AMP intermediate by soaking IbpAFic2 crystals in ATP-containing solutions were not successful (data not shown). Although we are still not certain about the nature and function of the autoadenylylation, the structural information we have obtained suggests that the highly conserved histidine in the HPFx(D/E)GN(G/K)R motif functions as a general base during catalysis. As shown in Figure 6a , structural superposition of wild-type IbpAFic2 and IbpAFic2 H3717A revealed little geometric alteration in the positions of the residues in the active-site region. We can thus examine the position of His3717 of the wild-type structure to evaluate its role during catalysis. Assuming that the side chain of His3717 adopts the same rotamer orientation as seen in the crystal structure, its NE atom will be only ~2.2 Å away from the O1P atom of the adenylylated tyrosine, which presumably corresponds to the hydroxylgroup oxygen of the unmodified tyrosine (Fig. 6a) . This suggests that the histidine functions to attract a proton from the tyrosine, which will prepare the tyrosine as a nucleophile to attack the α-phosphate of ATP (Fig. 6b) . This substrate-assisted attack of ATP is also consistent with our observation that IbpAFic2 hydrolyzes ATP very slowly in the absence of Rho GTPases (~8 molecules of AMP generated per molecule of IbpAFic2 per hour at 30 °C, Supplementary Fig. 8) .
DISCUSSION
In the late 1960s, the Stadtman laboratory reported that E. coli glutamine synthetase is modified on a tyrosine residue by the addition of AMP. This modification, named 'adenylylation' , has a key role in regulating glutamine synthetase activity. As such, adenylylation was demonstrated for the first time as a novel type of post-translational modification. However, the concept of protein adenylylation has remained largely quiescent until recently. As described earlier, both IbpA and VopS can elicit cytotoxicity by adenylylating Rho-family GTPases, albeit targeting different residues. These two proteins share no overall sequence homology except at a conserved HPFx(D/E)GN(G/K)R motif. This motif is found in ~2,700 bacterial proteins and has a single copy in the human genome. The function of the human protein, known as HYPE, is currently unclear; however, it also has the ability to adenylylate Rho GTPases in vitro 2 . Collectively, these findings suggest that adenylylation is a widely used post-translational modification present in both prokaryotes and eukaryotes. We have characterized the structure of a ternary complex containing IbpAFic2 and adenylylated Cdc42. Our structure elucidates the nucleotide-binding mechanism of the Fic proteins. From our structure-based analysis, we can further predict residues that are important for nucleotide binding in other Fic proteins. For example, we have shown that, by mutating relevant residues, we can disrupt the autoadenylylation of two other Fic proteins, N. meningitidis Fic and H. pylori Fic (Fig. 4e) . The active-site architecture also leads us to propose a catalytic mechanism used by IbpAFic2 and possibly all Fic proteins involving the highly conserved histidine as the general base (Fig. 6b) . In IbpAFic2, the side chain orientation of this histidine appears to be stabilized by the ring-stacking interaction from residue Phe3675 to further assist catalysis (Fig. 6a) . Curiously, a ring-featured side chain appears to be a common feature for residues corresponding to IbpAFic2 Phe3675 in many other Fic structures, and a phenylalanine is highly preferred (Fig. 4c,d and Supplementary Fig. 6 ). We also speculate that the P-loop within the HPFx(D/E)GN(G/K)R motif might contribute to the stabilization of the negatively charged pentahedral intermediate during catalysis. The βand γ-phosphates of ATP are most likely complexed with a Mg 2+ ion to facilitate the formation of pyrophosphate as a leaving group (Fig. 6b) . The rest of the HPFx(D/E)GN(G/K)R motif residues, such as Pro3718, Phe3719, Ala3720 and Glu3721 in IbpAFic2, potentially make contacts with the Mg 2+ -β,γ-pyrophosphate, as suggested by their spatial location in reference to the AMP moiety in our complex structure. This will make the β,γ-pyrophosphate a better leaving group to complete the catalytic reaction. Many aspects of our herein proposed catalytic mechanism are supported by a recent kinetic study on VopS 25 .
We have also unraveled how IbpAFic2 specifically targets the switch1 tyrosine residue of Rho-family GTPases. IbpAFic2 recognizes a three-dimensional epitope in the Rho-family proteins that involves their critical switch1 and switch2 regions, resulting in tight substrate specificity. The interaction is mediated by the arm domain and the Leu3668-Lys3670 clamp of IbpAFic2. Other proteins work on different substrates where alternative residues could be adenylylated. We have shown that VopS also requires a proper switch2 region in the Rho-family proteins for its function. Consistent with our results, the recently published VopS structure 25 (PDB 3LET) reveals an IbpAFic2 arm-like segment. Superposing VopS onto IbpAFic2 in our complex structure suggests that this segment is in a perfect position to interact with the switch2 region of Cdc42 (Supplementary Fig. 9 ). Nevertheless, VopS must contain distinct structural elements that account for its modification of the threonine instead of the tyrosine residue. Our modeled VopS-Cdc42 structure suggests that the long α2-α3 loop in the C-terminal domain of VopS is most likely responsible for determining this specificity. However, several side chain clashes exist between this region and the switch2 region of Cdc42 in this model, suggesting that this region likely undergoes a conformational change upon substrate binding. Notably, IbpAFic2-bound Cdc42 adopts a GDI-bound conformation in the complex structure. This is reminiscent of the effect that Yersinia pseudotuberculosis effector YpkA exerts on the Rho-family proteins 28 and might be another example of the molecular-mimicry strategy commonly used by bacterial effectors 29, 30 . Our complex structure suggests that IbpAFic2 has the ability to elicit a conformational change in the Rho-family proteins and to convert them into their inactive GDI-bound conformation. The GDI proteins can bind both the GDP-and GTP-bound forms of the small GTPases and inhibit their functions 24, 31 . By exerting a GDI-mimicry activity, IbpA could pursue the Rho-family proteins irrespective of their functional states in the cell. This is borne out by our crystal structure, which suggests that GDP-bound Cdc42 can be adenylylated by IbpAFic2 (Fig. 2a) .
In summary, we have determined the crystal structures of IbpAFic2 alone and in complex with its reaction product, adenylylated Cdc42. The structural information, coupled with biochemical and cell biology experiments, has provided fundamental insights into the molecular mechanism of IbpAFic2 function and may facilitate the design of therapeutically important inhibitors. Our study also sheds light on the catalytic process of Fic-mediated adenylylation, and we propose that our suggested catalytic mechanism is likely used by many of the more than 2,700 Fic proteins.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. Accession codes. Protein Data Bank: Atomic coordinates and structural factors for the IbpAFic2-Cdc42 and IbpAFic2 H3717A-Cdc42 complexes have been deposited with accession codes 3N3U and 3N3V, respectively.
